Back
Guidewire Software Vs. Corcept Therapeutics Industry Stock Comparison
Buy
76
GWRE
Guidewire Software
Last Price:
194.92
Seasonality Move:
3.91%
Buy
87
CORT
Corcept Therapeutics
Last Price:
59.57
Seasonality Move:
3.97%
Buy
76
Guidewire Software (GWRE)
is a Buy
Is Guidewire Software a Buy, Sell or Hold?
- The current Guidewire Software [GWRE] share price is $194.93. The Score for GWRE is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
- GWRE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
87
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $59.60. The Score for CORT is 87, which is 74% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
GWRE Stock Price Chart
What is Guidewire Software's stock price today?
-
The Guidewire Software share price today is $194.93
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GWRE is experiencing slight selling pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $59.60
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
GWRE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.72 | Buy |
Relative Strength Index (14 RSI): | 72.64 | Buy |
Chaikin Money Flow: | -368710 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (184.37 - 190.71) | Buy |
Bollinger Bands (100): | (140.31 - 180.55) | Buy |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.95 | Buy |
Relative Strength Index (14 RSI): | 80.63 | Buy |
Chaikin Money Flow: | 759215 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.11 - 51.89) | Buy |
Bollinger Bands (100): | (31.7 - 45.68) | Buy |
GWRE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 189.43 | Buy |
20-day SMA: | 188.57 | Buy |
50-day SMA: | 178.09 | Buy |
200-day SMA: | 138.73 | Buy |
8-day EMA: | 190.7 | Buy |
20-day EMA: | 187.65 | Buy |
50-day EMA: | 177.98 | Buy |
200-day EMA: | 144.58 | Buy |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 51.72 | Buy |
20-day SMA: | 49.28 | Buy |
50-day SMA: | 44.07 | Buy |
200-day SMA: | 32 | Buy |
8-day EMA: | 53.06 | Buy |
20-day EMA: | 49.83 | Buy |
50-day EMA: | 45.17 | Buy |
200-day EMA: | 35.31 | Buy |
Guidewire Software Earnings Growth & GWRE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.29 per share, and an increase next year of $0.67 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
Guidewire Software Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |